Search

Mersey Care Mersey Care colleagues should be familiar with the process which must be followed for considering information arising from an allegation or concern about the behaviour of any employee working either directly or indirectly with children or vulnerable adult(s)

his Policy defines the framework to ensure the Trust meets its obligations in relation to the Data Protection Act 2018, UK General Data Protection Regulation, Information Commissioner Officer’s Code of Practice for Data Sharing and national guidance from NHS England.

This policy is a set of guidelines for using social media to ensure all staff know what they are allowed to and prohibited from sharing and/or posting on social media channels in order to protect themselves, the Trust and its patients.

THIS POLICY DESCRIBES THE APPRAISAL PROCESS WITHIN MCFT. IT ENABLES MANAGERS AND COLLEAGUES TO UNDERSTAND ITS PURPOSE AS A METHOD OF IDENTIFYING AREAS FOR INDIVIDUAL GROWTH, OBJECTIVESETTING, INFORMING PAY STEP PROGRESSION, SUCCESSION PLANNING AND ITS COMPLIANCE AS A TRUST KPI.

Roles, responsibilities and accountability in relation to safeguarding children Children High Secure Services Clarity about information sharing Definitions of abuse and vulnerabilities Child protection process

Safeguarding is everyone's business. Employees need to know the appropriate actions to take in order to protect and safeguard adults from abuse. This policy has been developed to describe the responsibilities of employees and organisation for the recognition and prevention of abuse and clarify the actions to take when abuse is suspected or identified.

To provider guidance to staff to enable Mersey Care NHSFT to comply with the new Provider Selection Regime when procuring (or sub-contracting) relevent health care services, in line with relevent legislation and national guidance

This procedure describes the processes to enable the administration of non-Controlled Drug injectable medicines for patients attending the Treatment Room Service provided in Knowsley.

This procedure provides guidance to ensure that valpoate treatment is appropriately and safely used in accordance with regulatory requirements for all female children and women of childbearing potential and males under the age of 55 years. It advises health care professionals of the actions to be taken to educate patients on safe use of valproate and ensure awareness of the potential risk of birth defects and congenital malformations associated with taking valproate in pregnancy.

The objectives of this policy are to describe the standards expected and the supporting processes for 1 Clinical and administrative application of the Mental Health Act 1983 (MHA). 2 Describing the interface processes that exist between the Mental Health Act 1983, the Mental Capacity Act 2005 and the Deprivation of Liberty Safeguards. 3 Monitoring the clinical and administrative application of the MHA. 4 Supporting those applying or monitoring the MHA through cross-referencing with the Act’s Code of Practice and other relevant literature, documentation. 5 Review and monitoring of the above process.